“The new Evia platform which has been innovatively engineered to significantly reduce energy consumption, resulting in small sized devices and longevities of up to 13 years, is another example of BIOTRONIK’s commitment to develop the highest quality and the most technologically advanced bradycardia product portfolio,” commented Marlou Janssen, Vice President, Global Marketing and Sales, Cardiac Rhythm Management, BIOTRONIK. “In combination with the unique BIOTRONIK Home Monitoring technologies, the new Evia pacemaker series further strengthens our position as the leader in wireless remote patient management.”
